# Reanalysis of cryo-EM data reveals ALK-cytokine assemblies with both 2:1 and 2:2 stoichiometries

**Authors:** Jan Felix, Steven De Munck, J. Fernando Bazan, Savvas N. Savvides, Richard Hodge, Richard Hodge, Richard Hodge

PMC · DOI: 10.1371/journal.pbio.3003124 · PLOS Biology · 2025-04-10

## TL;DR

This study reanalyzed cryo-EM data and found that the ALK-ALKAL2 complex exists in both 2:1 and 2:2 stoichiometries, resolving conflicting reports.

## Contribution

The study reveals a significant population of 2:1 ALK-ALKAL2 complexes in previously analyzed data and provides a new 3.2 Å resolution structure.

## Key findings

- Over half of the ALK-ALKAL2 particles in the dataset follow a 2:1 stoichiometry.
- A 3.2 Å resolution 3D reconstruction of the 2:1 ALK-ALKAL2 complex was achieved using improved cryo-EM processing.
- The findings reconcile the receptor dimerization modes of ALK and LTK with a common mechanism.

## Abstract

Activation of Anaplastic lymphoma kinase (ALK) and leukocyte tyrosine kinase (LTK) by their cognate cytokines ALKAL2 and ALKAL1 plays important roles in development, metabolism, and cancer. Recent structural studies revealed ALK/LTK-cytokine assemblies with distinct stoichiometries. Structures of ALK-ALKAL2 and LTK-ALKAL1 complexes with 2:1 stoichiometry determined by X-ray crystallography contrasted the 2:2 ALK-ALKAL2 complexes determined by cryo-EM and X-ray crystallography. Here, we show based on reanalysis of the cryo-EM data deposited in EMPIAR-10930 that over half of the ALK-ALKAL2 particles in the dataset are classified into 2D and 3D classes obeying a 2:1 stoichiometry besides the originally reported structure displaying 2:2 stoichiometry. Unlike particles representing the 2:2 ALK-ALKAL2 complex, particles for the 2:1 ALK-ALKAL2 complex suffer severely from preferred orientations that resulted in cryo-EM maps displaying strong anisotropy. Here, we show that extensive particle orientation rebalancing in cryoSPARC followed by 3D refinement with Blush regularization in RELION constitutes an effective strategy for avoiding map artifacts relating to preferred particle orientations and report a 3D reconstruction of the 2:1 ALK-ALKAL2 complex to 3.2 Å resolution from EMPIAR-10930. This new cryo-EM structure together with the crystal structures of ALK-ALKAL2 and LTK-ALKAL1 complexes with 2:1 stoichiometry reconciles a common receptor dimerization mode for ALK and LTK and provides direct evidence for the presence of an ALK-ALKAL2 complex with 2:1 stoichiometry next to the reported 2:2 stoichiometric assembly in the EMPIAR-10930 dataset. Finally, our analysis emphasizes the importance of public deposition of raw cryo-EM data to allow reanalysis and interpretation.

The mechanistic understanding of the complex between the receptor ALK and its cytokine ligand ALKAL2 has been complicated by reports of diverse stoichiometries (2:1 vs 2:2). This study reanalyzes cryo-EM data originally interpreted as showing a 2:2 ALK-ALKAL2 complex, revealing that the dataset includes an even larger particle  population representing the 2:1 stoichiometry.

## Linked entities

- **Genes:** ALK (ALK receptor tyrosine kinase) [NCBI Gene 238], LTK (leukocyte receptor tyrosine kinase) [NCBI Gene 4058], ALKAL2 (ALK and LTK ligand 2) [NCBI Gene 285016], ALKAL1 (ALK and LTK ligand 1) [NCBI Gene 389658]
- **Proteins:** ALKAL2 (ALK and LTK ligand 2), ALKAL1 (ALK and LTK ligand 1)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, LTK (leukocyte receptor tyrosine kinase) [NCBI Gene 4058] {aka TYK1}
- **Diseases:** cancer (MESH:D009369)
- **Cell lines:** EMPIAR-10930 — Homo sapiens (Human), Transformed cell line (CVCL_AD75)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12017499/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12017499/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12017499/full.md

---
Source: https://tomesphere.com/paper/PMC12017499